Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions
Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions. // Digital Chinese Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1465324926010273?dgcid=rss_sd_all
Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions. Digital Chinese Medicine. https://www.sciencedirect.com/science/article/pii/S1465324926010273?dgcid=rss_sd_all
“Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions.” Digital Chinese Medicine.
@article{article5273,
title = {Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions},
journal = {Digital Chinese Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1465324926010273?dgcid=rss_sd_all}
}
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Matic Bartol, Tina Fink, Tina Tragin, Ema Pleško, Roman Jerala, Hana Esih, Aljaž Kravanja, Brina Štante, Valentina Bianco, Luka Fajs, Mojca Jež